WisdomTree Trust > WisdomTree Trust
WisdomTree BioRevolution Fund
$2.54M
Avg Monthly Net Assets
$2.48M
Total Assets
$115K
Total Liabilities
$2.37M
Net Assets
WisdomTree BioRevolution Fund is an Exchange-Traded Fund in WisdomTree Trust
from WisdomTree Trust,
based in New York,
United States of America.
The fund has one share class
and monthly net assets of $2.54M.
On August 28th, 2024 it reported 92 holdings, the largest
being State Street Global Advisors (4.8%), Twist Bioscience Corp (3.9%) and Novonesis (Novozymes) B (2.9%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| N/A | C000227588 | CBSX | WDNA |
Holdings
From latest NPORT-P, filed August 28th, 2024 for period ending June 30th, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X Genomics Inc | Long | Equity-common | US | $10K | 532 | 0.44 |
| Absci Corp | Long | Equity-common | US | $5K | 2K | 0.21 |
| Agenus Inc | Long | Equity-common | US | $19K | 1K | 0.81 |
| Agilent Technologies Inc | Long | Equity-common | US | $26K | 203 | 1.11 |
| Agios Pharmaceuticals Inc | Long | Equity-common | US | $55K | 1K | 2.31 |
| Allogene Therapeutics Inc | Long | Equity-common | US | $13K | 6K | 0.55 |
| Alnylam Pharmaceuticals Inc | Long | Equity-common | US | $35K | 143 | 1.47 |
| Amgen Inc | Long | Equity-common | US | $34K | 108 | 1.43 |
| Amicus Therapeutics Inc | Long | Equity-common | US | $29K | 3K | 1.21 |
| Archer-Daniels-Midland Co | Long | Equity-common | US | $21K | 349 | 0.89 |
| Arcturus Therapeutics Holdings Inc | Long | Equity-common | US | $27K | 1K | 1.14 |
| Arrowhead Pharmaceuticals Inc | Long | Equity-common | US | $25K | 948 | 1.04 |
| AstraZeneca PLC | Long | Equity-common | GB | $29K | 371 | 1.22 |
| Bayer AG | Long | Equity-common | DE | $19K | 683 | 0.82 |
| Beam Therapeutics Inc | Long | Equity-common | US | $25K | 1K | 1.06 |
| Beyond Meat Inc | Long | Equity-common | US | $15K | 2K | 0.65 |
| Bio-Rad Laboratories Inc | Long | Equity-common | US | $17K | 64 | 0.74 |
| Bio-Techne Corp | Long | Equity-common | US | $23K | 324 | 0.98 |
| Biogen Inc | Long | Equity-common | US | $23K | 98 | 0.96 |
| Biohaven Ltd | Long | Equity-common | VG | $16K | 464 | 0.68 |
| BioMarin Pharmaceutical Inc | Long | Equity-common | US | $23K | 274 | 0.95 |
| BioNTech SE | Long | Equity-common | DE | $19K | 236 | 0.80 |
| Blueprint Medicines Corp | Long | Equity-common | US | $65K | 600 | 2.73 |
| Bridgebio Pharma Inc | Long | Equity-common | US | $38K | 2K | 1.63 |
| Bristol-Myers Squibb Co | Long | Equity-common | US | $21K | 504 | 0.88 |
| Caribou Biosciences Inc | Long | Equity-common | US | $10K | 6K | 0.43 |
| Catalent Inc | Long | Equity-common | US | $33K | 578 | 1.37 |
| Corteva Inc | Long | Equity-common | US | $25K | 467 | 1.06 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $32K | 586 | 1.34 |
| CureVac NV | Long | Equity-common | NL | $10K | 3K | 0.43 |
| Danaher Corp | Long | Equity-common | US | $33K | 132 | 1.39 |
| Darling Ingredients Inc | Long | Equity-common | US | $26K | 712 | 1.11 |
| Dow Inc | Long | Equity-common | US | $28K | 525 | 1.18 |
| DuPont de Nemours Inc | Long | Equity-common | US | $32K | 394 | 1.34 |
| Editas Medicine Inc | Long | Equity-common | US | $20K | 4K | 0.83 |
| Eli Lilly & Co | Long | Equity-common | US | $60K | 66 | 2.53 |
| Exact Sciences Corp | Long | Equity-common | US | $19K | 443 | 0.79 |
| Fate Therapeutics Inc | Long | Equity-common | US | $34K | 10K | 1.43 |
| FMC Corp | Long | Equity-common | US | $16K | 275 | 0.67 |
| Genmab A/S | Long | Equity-common | DK | $25K | 996 | 1.06 |
| Genus PLC | Long | Equity-common | GB | $12K | 562 | 0.50 |
| Geron Corp | Long | Equity-common | US | $58K | 14K | 2.47 |
| Gilead Sciences Inc | Long | Equity-common | US | $23K | 337 | 0.98 |
| Ginkgo Bioworks Holdings Inc | Long | Equity-common | US | $8K | 23K | 0.33 |
| GRAIL Inc | Long | Equity-common | US | $489.27 | 31.83 | 0.02 |
| Green Plains Inc | Long | Equity-common | US | $17K | 1K | 0.70 |
| Illumina Inc | Long | Equity-common | US | $20K | 191 | 0.84 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $17K | 770 | 0.73 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $34K | 719 | 1.45 |
| Iovance Biotherapeutics Inc | Long | Equity-common | US | $37K | 5K | 1.58 |
| Johnson & Johnson | Long | Equity-common | US | $26K | 175 | 1.08 |
| Labcorp Holdings Inc | Long | Equity-common | US | $25K | 124 | 1.07 |
| Lenzing AG | Long | Equity-common | AT | $16K | 448 | 0.66 |
| Merck & Co Inc | Long | Equity-common | US | $30K | 245 | 1.28 |
| Moderna Inc | Long | Equity-common | US | $21K | 179 | 0.90 |
| Myriad Genetics Inc | Long | Equity-common | US | $33K | 1K | 1.38 |
| Natera Inc | Long | Equity-common | US | $59K | 544 | 2.49 |
| NeoGenomics Inc | Long | Equity-common | US | $25K | 2K | 1.06 |
| Novartis AG | Long | Equity-common | CH | $32K | 302 | 1.37 |
| Novonesis (Novozymes) B | Long | Equity-common | DK | $68K | 1K | 2.86 |
| Nufarm Ltd | Long | Equity-common | AU | $17K | 6K | 0.73 |
| Nutrien Ltd | Long | Equity-common | CA | $19K | 382 | 0.82 |
| Origin Materials Inc | Long | Equity-common | US | $12K | 13K | 0.49 |
| Oxford Nanopore Technologies PLC | Long | Equity-common | GB | $13K | 11K | 0.56 |
| Pacific Biosciences of California Inc | Long | Equity-common | US | $3K | 3K | 0.15 |
| Pfizer Inc | Long | Equity-common | US | $21K | 745 | 0.88 |
| Precigen Inc | Long | Equity-common | US | $10K | 6K | 0.41 |
| QIAGEN NV | Long | Equity-common | NL | $26K | 623 | 1.08 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $36K | 34 | 1.51 |
| REGENXBIO Inc | Long | Equity-common | US | $19K | 2K | 0.79 |
| Repligen Corp | Long | Equity-common | US | $21K | 169 | 0.90 |
| Sana Biotechnology Inc | Long | Equity-common | US | $14K | 3K | 0.61 |
| Sarepta Therapeutics Inc | Long | Equity-common | US | $47K | 298 | 1.99 |
| Schrodinger Inc/United States | Long | Equity-common | US | $18K | 910 | 0.74 |
| Solvay SA | Long | Equity-common | BE | $8K | 229 | 0.34 |
| State Street Navigator Securities Lending Government Money Market Portfolio (State Street Global Advisors) | Long | Short-term investment vehicle | US | $114K | 114K | 4.82 |
| Stoke Therapeutics Inc | Long | Equity-common | US | $30K | 2K | 1.26 |
| Syensqo SA | Long | Equity-common | BE | $30K | 334 | 1.26 |
| Takara Bio Inc | Long | Equity-common | JP | $10K | 1K | 0.41 |
| Takeda Pharmaceutical Co Ltd | Long | Equity-common | JP | $21K | 792 | 0.87 |
| Thermo Fisher Scientific Inc | Long | Equity-common | US | $28K | 50 | 1.17 |
| Twist Bioscience Corp | Long | Equity-common | US | $93K | 2K | 3.94 |
| Tyson Foods Inc | Long | Equity-common | US | $28K | 483 | 1.17 |
| Ultragenyx Pharmaceutical Inc | Long | Equity-common | US | $29K | 707 | 1.23 |
| United Therapeutics Corp | Long | Equity-common | US | $36K | 113 | 1.52 |
| Veracyte Inc | Long | Equity-common | US | $28K | 1K | 1.19 |
| Verbio SE | Long | Equity-common | DE | $10K | 560 | 0.44 |
| Vericel Corp | Long | Equity-common | US | $48K | 1K | 2.02 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $38K | 81 | 1.60 |
| Verve Therapeutics Inc | Long | Equity-common | US | $10K | 2K | 0.44 |
| Vitrolife AB | Long | Equity-common | SE | $18K | 1K | 0.74 |
| Zoetis Inc | Long | Equity-common | US | $28K | 161 | 1.18 |
Address
WisdomTree Trust
250 West 34th Street
3rd Floor
New York
New York
10119
United States of America
Websites
Directors
Victor Ugolyn
Toni Massaro
David G. Chrencik
Joel Goldberg
Robert E. Plaze
Melinda A. Raso Kirstein
Phillip Goff
Jonathan Steinberg
Transfer Agents
State Street Bank and Trust Company
Pricing Services
London Stock Exchange Group PLC
Bloomberg L.P.
ICE Data Services, Inc.
PricingDirect Inc.
Custodians
Skandinaviska Enskilda Banken AB (Oslo, Oslo, NO, Branch)
Citibank, National Association (Singapore, SG, Branch)
State Street Bank International GmbH
State Street Bank and Trust Company
Euroclear Bank
HSBC Bank (China) Company Limited
Bank Hapoalim B.M.
Intesa Sanpaolo S.p.A.
Mizuho Bank, Ltd. (Minato ku, Tokyo, JP, Branch)
Citibank Europe Public Limited Company
UniCredit Bank Austria AG
Skandinaviska Enskilda Banken AB (Helsinki, Uusimaa, FI, Branch)
The Hongkong and Shanghai Banking Corporation Limited (Sydney, NSW, AU, Branch)
Skandinaviska Enskilda Banken AB
State Street Trust Company Canada
State Street Bank and Trust Company (Edinburgh, GB, Branch)
Royal Bank of Canada
BNP Paribas
The Hongkong and Shanghai Banking Corporation Limited
UBS Switzerland AG
Skandinaviska Enskilda Banken AB (Copenhagen, Hovedstaden, DK, Branch)
Shareholder Servicing Agents
State Street Bank and Trust Company
Admins
State Street Bank and Trust Company
Brokers
Goldman Sachs & Co. LLC
Nomura Securities International, Inc.
Morgan Stanley & Co. LLC
CA Indosuez
Piper Sandler & Co.
Hilltop Securities Inc.
UBS Securities LLC
Sanford C. Bernstein & Co., LLC
BofA Securities, Inc.
J.P. Morgan Securities LLC